Showing results (131-140 of 154) with videos related to

Sort By:
Pageof 16
Clinical Colorectal Cancer|November 21, 2021
The Role of Intestinal Microbiota in Metastatic Colorectal Cancer Patients Treated With CapecitabineRomy Aarnoutse, Janine Ziemons, Judith de Vos-Geelen, et al.
Travel Medicine and Infectious Disease|December 22, 2019
Prevalence and risk factors for carriage of ESBL-producing Enterobacteriaceae in a population of Dutch travellers: A cross-sectional studyMaris S Arcilla, Jarne M Van Hattem, Martin C J Bootsma, et al.
Cancers|December 24, 2021
Intestinal Microbiota in Postmenopausal Breast Cancer Patients and ControlsRomy Aarnoutse, Lars E Hillege, Janine Ziemons, et al.
The Lancet. Infectious Diseases|October 19, 2016
Import and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort studyMaris S Arcilla, Jarne M van Hattem, Manon R Haverkate, et al.
Medrxiv : the Preprint Server for Health Sciences|November 1, 2024
Metagenomic analysis during capecitabine therapy reveals microbial chemoprotective mechanisms and predicts drug toxicity in colorectal cancer patientsLars E Hillege, Kai R Trepka, Janine Ziemons, et al.
Scientific Reports|November 12, 2017
Global phylogenetic analysis of Escherichia coli and plasmids carrying the mcr-1 gene indicates bacterial diversity but plasmid restrictionSébastien Matamoros, Jarne M van Hattem, Maris S Arcilla, et al.
Pageof 16